VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒═══════════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                     │   Score │
╞═══════════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Males and females with confirmed disease: Fabry   │ Males and females with confirmed disease: Fabry   │     100 │
│ (by GLA enzymes and/or DNA testing) naïve and on  │ (by GLA enzymes and/or DNA testing) naïve and on  │         │
│ ERT, Mitochondrial diseases (electron transport   │ ERT, Mitochondrial diseases (electron transport   │         │
│ chain and/or DNA testing) or connective tissue    │ chain and/or DNA testing) or connective tissue    │         │
│ diseases (clinical criteria and/or DNA testing    │ diseases (clinical criteria and/or DNA testing    │         │
│ when available)                                   │ when available)                                   │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Consenting adults (18 years and older) who agrees │ Consenting adults (18 years and older) who agrees │     100 │
│ and consents to skin biopsy and QSART procedure   │ and consents to skin biopsy and QSART procedure   │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Subjects with cognitive, psychiatric, or other    │ Subjects with cognitive, psychiatric, or other    │     100 │
│ problems that preclude informed consent           │ problems that preclude informed consent           │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patients with history of glucose intolerance or   │ Patients with history of glucose intolerance or   │     100 │
│ diabetes                                          │ diabetes                                          │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patient on chemotherapy                           │ Patient on chemotherapy                           │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ People with any open or bleeding wounds at any    │ People with any open or bleeding wounds at any    │     100 │
│ sensor plate contact surface location             │ sensor plate contact surface location             │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ People with any type of implantable device        │ People with any type of implantable device        │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ People with missing hand(s) and/or leg(s)         │ People with missing hand(s) and/or leg(s)         │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Pregnant women or women who are uncertain about a │ Pregnant women or women who are uncertain about a │     100 │
│ possible pregnancy                                │ possible pregnancy                                │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patients sensitive to chemicals used to induce    │ Patients sensitive to chemicals used to induce    │     100 │
│ sweating                                          │ sweating                                          │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patients with heat intolerance                    │ Patients with heat intolerance                    │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patients with bleeding disorders                  │ Patients with bleeding disorders                  │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patients on current anticoagulant therapy         │ Patients on current anticoagulant therapy         │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patients with keloids on the intended biopsy site │ Patients with keloids on the intended biopsy site │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ People with hypersensitivity to local amide-type  │ People with hypersensitivity to local amide-type  │     100 │
│ anesthetics                                       │ anesthetics                                       │         │
╘═══════════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                  │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════════╪═════════╡
│ Must have maximum age of 70 Years │ Patients sensitive to chemicals used to induce │      34 │
│                                   │ sweating                                       │         │
├───────────────────────────────────┼────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 8 Years  │ Patients with bleeding disorders               │      38 │
╘═══════════════════════════════════╧════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 92.47058823529412
OverAll Ratio: 94.73529411764706
